Tablets Ksizal film-coated 5 mg, # 14

Ksizal tab.

p / o captivity.

5mg No. 14

Name ENG

XYZAL

Clinical and pharmacological group

Blocker of histamine H1 receptors.

Antiallergic drug

ATX code

Levocetirizine

Dosage

5mg

Structure

1 tablet contains 5 mg levocetirizine dihydrochloride.

Indications

Symptomatic therapy of allergic diseases and conditions: - year-round (persistent) and seasonal (intermittent) allergic rhinitis and allergic conjunctivitis (itching, sneezing, rhinorrhea, lacrimation, conjunctival hyperemia, nasal congestion)

- hay fever (hay fever)

- urticaria (including chronic idiopathic urticaria)

- Quincke's edema

- other allergic dermatoses, accompanied by itching and rashes.

Contraindications

Terminal stage of renal failure (CC less than 10 ml / min)

- children under 6 years of age (for tablets)

- children under 2 years of age (for oral drops)

- pregnancy

- hypersensitivity to the components of the drug, especially in patients with galactosemia or severe lactose intolerance (for tablets)

- hypersensitivity to levocetirizine or piperazine derivatives.

The drug should be used with caution in chronic renal failure (dosage adjustment is required), in elderly patients (with age-related decrease in glomerular filtration).

Storage conditions and periods

In a dry place, at a temperature not exceeding 25 degrees.

Expiration date: 4 years

INN / Active ingredient

Levocetirizine

Specifications

Category

Allergy

Scope of the drug

Leather

,

Dermatology

Release form

Tablet

Manufacturer country

Switzerland

Package quantity, pcs

14

Scope of application

Allergology

Minimum age from

6 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

UCB Farchim

The amount of the dosage form in the primary package

7 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

R06AE09 Levocetirizine

Dosage form

Film-coated tablets

Dosage (volume) of the substance in the preparation

levocetirizine dihydrochloride 5 mg

Expiration date in days

1461

Package weight, g

ten

Mode of application

:

It is taken orally with food or on an empty stomach, with a small amount of water without chewing.

Adults and children over 6 years old: daily dose - 5 mg (1 tablet).

Elderly patients (subject to normal renal function) dose reduction is not required.

For patients with chronic renal failure, the dose is reduced by half (1 tablet every other day) with CC from 30 to 49 ml / min and 3 times (1 tablet every 3 days) with CC from 10 to 29 ml / min.

Patients with hepatic insufficiency do not need to correct the dosage regimen.

< br> The duration of admission depends on the disease.

For the treatment of pollinosis, it is prescribed on average for 1-6 weeks.

In chronic diseases (perennial rhinitis, atonic dermatitis), the duration of treatment may increase to 18 months.

Pharmaco-therapeutic group

:

Antiallergic agent - H1-histamine receptor blocker